FDA Approved: ERZOFRI EXTENDED-RELEASE — Original Application (Shandong Luye Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved a new extended-release product, ERZOFRI EXTENDED-RELEASE, containing paliperidone palmitate under an original NDA from Shandong Luye Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ERZOFRI EXTENDED-RELEASE (PALIPERIDONE PALMITATE)

Snippet

ORIG AP for ERZOFRI EXTENDED-RELEASE (PALIPERIDONE PALMITATE)